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Introduction {#sec1}
============

The formation of the mammalian cortex, a complex multilayered structure, requires the birth of neurons in the ventricular and subventricular zones followed by phases of bipolar and multipolar migration before newly born neurons arrive at their final destination in the cortical plate ([@bib5]). This sophisticated cellular journey relies on a myriad of intracellular and intercellular signaling factors that converge on the cytoskeleton ([@bib1]). The importance of the microtubule cytoskeleton in the sequential steps involved in migration and differentiation is reflected in the finding that mutations in various tubulin genes cause a range of structural brain abnormalities. Mutations in the α-tubulin subunit *TUBA1A* have been shown to result in lissencephaly ([@bib9]); mutations in the β-tubulin subunit *TUBB2B* cause asymmetric polymicrogyria ([@bib8]); and it has been shown that mutations in *TUBB3* cause an ocular motility disorder ([@bib21]), as well as a broad range of cortical abnormalities ([@bib19]). Most recently, the tubulin genes *TUBA1A* and *TUBB2B* have also been implicated in autism spectrum disorders ([@bib15]; [@bib18]). Together, these studies have implicated specific tubulin isotypes in postmitotic cellular events, but those isotypes that mediate the generation of neurons, a process that requires the assembly of microtubules into a highly organized mitotic spindle, remain unknown ([@bib16]). Here, we set out to identify those tubulin genes required for cortical neurogenesis. We report that the β-tubulin gene *TUBB5* is highly expressed in the developing cortex and that mutations in this gene cause microcephaly, with a range of structural brain abnormalities that include dysmorphic basal ganglia, dysgenesis of the corpus callosum, brainstem hypoplasia, and focal polymicrogyria.

Results and Discussion {#sec2}
======================

*Tubb5* Is Expressed at High Levels in the Developing Brain {#sec2.1}
-----------------------------------------------------------

We surveyed the expression of all known β-tubulin genes in the developing mouse (E10.5, E12.5, E14.5, E16.5, P0) and human (gestational week \[GW\] 13, GW22) cortex by quantitative real-time PCR ([@bib2]). We observed consistently high expression levels of *Tubb2b*, *Tubb3,* and *Tubb5*, with *Tubb5* the highest expressed isotype in the embryonic mouse brain ([Figures 1](#fig1){ref-type="fig"}A and 1B). We investigated the spatial expression of *Tubb5* by in situ hybridization at embryonic day (E) 12.5, E14.5, and E16.5 ([Figures 1](#fig1){ref-type="fig"}C--1H). This revealed robust expression throughout the developing cortex, particularly in the subventricular zone (SVZ) at E14.5, which was absent in sense controls ([Figures S1](#figs1){ref-type="fig"}A--S1C). Because there are no validated antibodies that are specific for *Tubb5,* we created a transgenic mouse line that drives enhanced green fluorescent protein (EGFP) from the endogenous *Tubb5* promoter to determine which cell types express *Tubb5* ([Figures S1](#figs1){ref-type="fig"}D--S1Q). This mouse recapitulated our in situ hybridization results and demonstrated that *Tubb5* is expressed in radial glial cells (Pax6 positive), intermediate progenitors (Tbr2 positive), migrating neurons (Dcx positive), and postmitotic neurons (Tuj positive; [Figures 1](#fig1){ref-type="fig"}I--1X).

Depletion of *Tubb5* Perturbs the Progenitor Cell Cycle and the Migration of Neurons {#sec2.2}
------------------------------------------------------------------------------------

We investigated the effect of *Tubb5* depletion on cortical development in mice by employing a small hairpin RNA (shRNA) that targets its 3′UTR. Following validation of this shRNA in Neuro-2a cells ([Figure S2](#figs2){ref-type="fig"}A), we electroporated it into progenitor cells of the ventricular zone (VZ) at E14.5, together with a GFP expressing vector ([Figure 2](#fig2){ref-type="fig"}A). Quantification of the fraction of GFP-positive cells that coexpress pH3 (mitotic index) after 36 hr of knockdown revealed an increase in the percentage of these mitotic cells in the VZ/SVZ when *Tubb5* was depleted (n = 6; p \< 0.001). This effect could be rescued by codelivering a *Tubb5* expression construct that lacked the shRNA targeting sequence ([Figures 2](#fig2){ref-type="fig"}B--2D; [Figures S2](#figs2){ref-type="fig"}D and S2E; [Table S2](#mmc1){ref-type="supplementary-material"}) and replicated when employing an alternative shRNA (data not shown). Because mutations in *Tuba1a* have been shown to induce apoptosis, we studied cell survival by staining for cleaved caspase-3 at E16, following electroporation at E14.5 ([@bib4]). This revealed no statistically significant difference between conditions, but we cannot exclude the possibility of increased apoptosis following long-term depletion of *Tubb5* ([Figures S2](#figs2){ref-type="fig"}F--S2O). Next, we investigated the effect of *Tubb5* depletion on neuronal migration by electroporating our shRNA at E14.5 and harvesting embryos 72 hr later (migration index). In comparison to controls, we observed a significant decrease in the percentage of GFP-labeled cells in the cortical plate (CP) when *Tubb5* was depleted, concomitant with an accumulation of cells within the VZ and intermediate zone (IZ) (n ≥ 5; VZ: p \< 0.05; IZ: p \< 0.05; CP: p \< 0.01; [Figures 2](#fig2){ref-type="fig"}E--2G; [Figures S2](#figs2){ref-type="fig"}B and S2C; [Table S2](#mmc1){ref-type="supplementary-material"}). To assess whether *Tubb5* depletion affects the final positioning of neurons, we harvested brains at postnatal day (P) 17, following electroporation at E14.5. Quantification of the percentage of GFP positive cells in the six layers of the P17 cortex showed that *Tubb5* knockdown results in a long-term positioning defect (n = 4; layer VI: p \< 0.05; layers II--IV: p \< 0.01) ([Figure 2](#fig2){ref-type="fig"}H). We conclude that *Tubb5* depletion perturbs the neurogenic cell cycle and alters the positioning of migrating neurons.

Mutations in *TUBB5* Cause Microcephaly in Humans {#sec2.3}
-------------------------------------------------

On the basis of these results, we surmised that mutations in *TUBB5* might cause neurodevelopmental disease in humans. We therefore screened a panel of patients with a range of brain malformations, resulting in the identification of three unrelated microcephalic individuals harboring de novo mutations in *TUBB5* (M299V, V353I, and E401K) ([Figures S3](#figs3){ref-type="fig"}A--S3C). Each individual presented with microcephaly (with an orbitofrontal cortex \[OFC\] ranging from −2.5 SD to −4 SD), dysmorphic basal ganglia, corpus callosum abnormalities, and cognitive impairment with motor and language delay ([Table 1](#tbl1){ref-type="table"}; [Figures 3](#fig3){ref-type="fig"}A--3F; [Figures S3](#figs3){ref-type="fig"}E and S3F). Two of the patients (M299V and V353I) shared unusual white matter streaks with a radial orientation through the lenticular nucleus, as well as brainstem hypoplasia ([Figures 3](#fig3){ref-type="fig"}A--3F). The child harboring the V353I mutation originates from a family with a history of microcephaly (without mental retardation), raising the prospect that another genetic factor contributes to his disease. Sequencing of known microcephaly genes (*MCPH1*, *CD5KRAP2*, *WDR62*, *ASPM*) and the known disease causing tubulins (*TUBA1A*, *TUBB2B,* and *TUBB3*) did not identify any pathogenic variants in the patients described. A search of publicly available genomic databases showed that the M229V, V353I, and E401K mutations are not present in the general population. Moreover, screening of ethnically relevant controls (French/Caucasian, 238; Vietnamese, 115; Indian subcontinent, 252) failed to identify these variants. Homology analysis showed that these residues are highly conserved in all human β-tubulins and related tubulin isotypes from yeast to humans ([Figure S3](#figs3){ref-type="fig"}D).

Functional Analysis of Disease-Causing Mutations {#sec2.4}
------------------------------------------------

We mapped the location of the affected residues onto the known structure of the α/β heterodimer ([Figures 3](#fig3){ref-type="fig"}G--3J). M299 lies in a loop following helix 9, with its side chain protruding into a deep hydrophobic pocket. V353 lies on the intradimer interface, whereas E401, which precedes helix 12, lies on the surface of the interdimer interface. This residue is in close proximity to a loop (αα98--104) that is critical for nucleotide binding ([@bib14]) and that may be reoriented by substitution with a lysine residue. All three mutations have the potential to compromise either the complex chaperone-dependent reactions that are essential for tubulin heterodimer assembly or the dynamic behavior of microtubules ([@bib20]). To address these issues, we monitored the expression and folding of the mutant proteins kinetically in rabbit reticulocyte lysate. Analysis of the products under denaturing conditions showed that the translation efficiency of all three mutants was similar to the wild-type control ([Figure 3](#fig3){ref-type="fig"}K). However, analysis of the same reaction products under native conditions revealed quantitative and qualitative differences ([Figure 3](#fig3){ref-type="fig"}L). The wild-type protein and V353I and M299V mutants produced the expected folding intermediates (CCT/β, TBCD/β, PFD/β, and TBCA/β) ([@bib3]) before generating α/β heterodimers when chased with native bovine tubulin, but with a notable reduction in yield for the M299V mutation. In the case of the E401K mutation, the assembly pathway was arrested, with a conspicuous retention of the mutant polypeptide complexed with prefoldin (PFD) and the cytosolic chaperonin (CCT), and a dearth of native α/β heterodimers. We also examined the capacity of the TUBB5 mutants to incorporate into the microtubule network in Neuro-2a cells ([Figures 3](#fig3){ref-type="fig"}M--3X). Whereas the wild-type M299V and V353I proteins coassembled into interphase microtubules, we found that the E401K mutant protein failed to do so and was diffusely distributed throughout the cytoplasm. We conclude that the V353I and M299V mutations do not affect the ability of the mutant polypeptides to assemble into heterodimers and incorporate into microtubules, although the yield in the case of M299V may be compromised. In contrast, the E401K mutation results in a severe ablation of TUBB5 function, as it results in a massive failure of chaperone-mediated heterodimer assembly with a consequent inability of the mutant protein to incorporate into microtubules.

Effects of Human Mutations on Murine Neuronal Development {#sec2.5}
---------------------------------------------------------

To examine the effect of these mutations in vivo, we used in utero electroporation to overexpress the mutant forms of *Tubb5* in the developing mouse brain. While overexpression of wild-type *Tubb5* had no effect on the mitotic index (n = 5; p \> 0.5), we found a large increase in the percentage of GFP/pH3-colabeled cells in the VZ and SVZ when expressing the E401K and V353I mutants, similar to our *Tubb5* depletion experiments (n = 5; p \< 0.001 for both mutants; [Figures 4](#fig4){ref-type="fig"}A, 4D, and 4E). Electroporation of the M299V expression construct also resulted in a modest increase in the mitotic index within the cortical germinal zone (VZ + SVZ), although this increase was not statistically significant (n = 5; p \> 0.05; [Figures 4](#fig4){ref-type="fig"}A and 4C). We also examined the migratory index following expression of the *Tubb5* mutants. In comparison to controls, we found that expression of all three mutants resulted in a significant increase in the percentage of GFP-positive cells in the IZ and a corresponding decrease in the CP that was most severe in the case of the V353I mutant (n = 5; M299V: IZ: p \< 0.001; CP: p \< 0.01; V353I: VZ: p \< 0.01; IZ: p \< 0.001; CP: p \< 0.001; E401K: IZ: p \< 0.001; CP: p \< 0.01; [Figures 4](#fig4){ref-type="fig"}B and 4G--4I). These changes were not observed upon overexpression of wild-type *Tubb5* alone (n = 5; p \> 0.05; [Figure 4](#fig4){ref-type="fig"}F). Analysis of neurons at P17 following the overexpression of *Tubb5* mutants revealed aberrant clusters of ectopic cells in deep layers of the cortex ([Figure S4](#figs4){ref-type="fig"}). Quantification showed that in comparison to controls, this results in fewer cells in superficial layers of the cortex (n ≥ 2; M299V: II--IV: p \< 0.05; E401K: II--IV: p \< 0.001) and an accumulation of GFP-positive cells in the deeper layers (E401K: n = 3; VI: p \< 0.01), but this was not significant in the case of the V353I mutation (n = 3; VI: p \> 0.05). This result demonstrates that the migratory defects described above have a long-term effect on neuronal position, and consequently on the structural architecture of the brain. Together, these data support our conclusion that the mutations are pathogenic, with an effect on both the generation and subsequent migration of neurons.

The three mutations we identified (M299V, V353I, and E401K) are likely to act by different molecular mechanisms ([@bib23]). The impairment in heterodimer assembly observed in the case of the E401K and M299V mutations suggests that they act by loss-of-function; however, the marked phenotype that results from heterologous expression of all mutants in vivo raises the prospect of a dominant-negative effect. It is conceivable that kinetically trapped E401K and M299V polypeptides have a deleterious effect on the entire chaperone-mediated tubulin folding and assembly pathway, while the V353I mutation may alter the dynamic properties of microtubules or compromise the binding of one or more essential microtubule associated proteins ([@bib11]; [@bib21]; [@bib23]). The underlying cellular pathology is likely to be equally as complex. We have shown that both knockdown of Tubb5 and overexpression of Tubb5 mutants result in a paradoxical increase in pH3 reactivity. There are a number of explanations for this unexpected result, which implies an increase in mitotic output. First, it is conceivable that there is an elongation of M-phase, which delays progression of the cell cycle and the generation of neurons ([@bib13]). Second, it is possible that hyperproliferating apical progenitors result in fewer intermediate progenitors, and consequently an overall reduction in postmitotic neurons ([@bib10]). Third, M-phase arrest may, at a later point in time, result in increased apoptosis, accounting for the incongruity between our in vivo pH3 results and the human phenotype. Further studies focused on the timing and output of the cell cycle will be necessary to establish which of the aforementioned mechanisms are responsible.

It is apparent from this study that patients with mutations in *TUBB5* share structural brain abnormalities in common with the previously described tubulinopathies (*TUBA1A*, *TUBB2B*, *TUBB3*), including dysmorphic basal ganglia, abnormalities of the corpus callosum, and brainstem phenotypes ([@bib22]). The distinguishing feature of *TUBB5*-associated disease is microcephaly, which we attribute to the high level of *TUBB5* expression in neuronal progenitors. This contrasts with *TUBA1A*, *TUBB2B,* and *TUBB3,* all of which are largely restricted in their expression to postmitotic neurons in the developing brain ([@bib6]; [@bib8]; [@bib12]). *TUBB5* may have a specific function in mitotically active cells, or alternatively make a critical contribution to the supply of tubulin heterodimers. In either event, our work provides insight into the functional repertoire of the tubulin gene family, specifically implicating *TUBB5* in embryonic neurogenesis and microcephaly.

Experimental Procedures {#sec3}
=======================

Animals {#sec3.1}
-------

Animals were maintained within the animal research laboratories of the Institute of Molecular Pathology and Monash University on a 12:12 light:dark cycle with food available ad libitum. All procedures were performed in accordance with existing animal licenses and guidelines (M58-006093-2011-13 B).

Generation of Tg(Tubb5-EGFP) Mice {#sec3.2}
---------------------------------

The Red/ET system (*K001*, Gene Bridges) was employed to replace the endogenous *Tubb5* (*RP24-330C1*) with EGFP. Following generation of the construct, we proceeded with pronuclear injection and PCR screening to confirm germline transmission before immunostaining.

In Situ Hybridization {#sec3.3}
---------------------

C57/BL6 embryos were harvested, postfixed in 4% paraformaldehyde (PFA), dehydrated in a pressure- and temperature-controlled environment, embedded in paraffin, and sectioned (14 μm). We then proceeded with in situ hybridization as previously described ([@bib2]).

Real-Time Quantitative PCR {#sec3.4}
--------------------------

Embryonic, postnatal, and adult tissues (C57/BL6) were dissected and snap frozen before mRNA extraction and reverse transcription. Quantitative real-time PCR followed employing exon spanning primers and three internal control genes. For human studies, fetal brain cDNA was obtained from Yorkshire Biosciences.

In Utero Electroporation Experiments {#sec3.5}
------------------------------------

Sequence-verified constructs for wild-type and mutant versions of *Tubb5* were cloned into pCIG2. shRNAs optimized for specific knockdown of *Tubb5* were cloned into the pSuper vector system. In utero electroporation, cryosectioning, and immunostaining were performed as previously described ([@bib7]; [@bib17]). Cell counting was performed blind to the condition on representative fields of sections of electroporated brains using ImageJ software.

Biochemical and Cellular Studies {#sec3.6}
--------------------------------

Plasmids encoding the *Tubb5* mutants were expressed in rabbit reticulocyte lysate (Promega) as described ([@bib20]) before analysis on native polyacrylamide gels. For cellular studies, FLAG-tagged TUBB5 DNA constructs were transfected into Neuro-2a cells before immunostaining with an anti-α-tubulin antibody (Sigma, T6199-200UL) and an anti-FLAG antibody (Abcam, ab1162).

Human Studies {#sec3.7}
-------------

We obtained DNA and informed consent according to the guidelines of local institutional review boards at Cochin Hospital and INSERM. *TUBB5* was screened in 120 individuals with sporadic structural brain abnormalities that included lissencephaly, polymicrogyria, microcephaly, and nodular heterotopia. These patients had previously been screened for mutations in the known disease-causing tubulin genes (*TUBA1A, TUBB2B, TUBB3*), and (depending on their phenotype) for other pathogenic genes (e.g., *DCX, LIS1, FLNA*). Following the identification of de novo mutations in *TUBB5,* parental relationships were confirmed using a suite of microsatellite markers.

Statistics {#sec3.8}
----------

Statistical analysis was performed with the GraphPad Prism 5 software package. For experiments with two conditions, we performed a Student's t test. For experiments with multiple conditions, we used a one-way ANOVA followed by Bonferroni multiple comparison test.

For additional details, please see the [Extended Experimental Procedures](#dtbox1){ref-type="boxed-text"}.

Extended Experimental ProceduresGeneration and Immunostaining of Tg(Tubb5-EGFP) MiceA Bacterial Artificial Chromosome (BAC; *RP24-330C1*) containing the *Tubb5* gene was first validated by restriction enzyme (FspI) and PCR analysis. We employed high fidelity PCR to amplify a GFP-FRT-NEO-FRT cassette flanked by 60 base pair sequences homologous to the *Tubb5* locus (see [Table S1](#mmc1){ref-type="supplementary-material"}), and employed the Red/ET system (*K001*, Gene Bridges) to replace the endogenous *Tubb5* gene. Following excision of the neomycin resistance cassette with a 707-FLPe plasmid (*A104*, Gene Bridges), we proceeded with pronuclear injection, and PCR screening for genomic incorporation (see [Table S1](#mmc1){ref-type="supplementary-material"}). Embryos were harvested at E12.5, E14.5 and E16.5 and fixed in 4% PFA overnight before dehydration in 30% sucrose overnight, embedding and sectioning (12 μm). Sections were incubated with the primary antibody overnight in 0.1%--0.3% triton/PBS with 2% of the appropriate serum at the following concentrations: Dcx (1:100, Santa Cruz), Tuj1 (1:1000, Covance), Tbr2 (1:200, Abcam), Pax6 (1:300, Covance). For Tbr2 and Pax6 staining we performed antigen retrieval with citrate buffer (0.01M, pH6.0); slides were heated from room temperature to 90°C in a water bath and then placed at to room temperature for 20 min prior to incubation with the primary antibody overnight (14-16 hr) at 4°C. The next day, sections were washed 3 times in PBS (5 min each), before application of a species specific secondary antibody (Molecular Probes) for 1 hr in 0.1%--0.3% triton/PBS. Sections were then mounted in VectaShield Mounting Medium (hard set with DAPI). Microscopy was performed on a Zeiss LSM 710, with the exception of the low magnification images of the Tg(Tubb5-EGFP) embryos that were captured with a Mirax slide scanner (Zeiss).In Situ HybridizationC57/BL6 embryos were harvested at E12.5, E14.5 and E16.5, post-fixed in 4% PFA, dehydrated in a pressure and temperature controlled environment, embedded in paraffin and sectioned (14 μm). Prior to in situ hybridization these sections were de-paraffined employing standard protocols. A 165 base pair probe for in situ hybridization was amplified by PCR (see [Table S1](#mmc1){ref-type="supplementary-material"}), cloned into a pCRII-TOPO vector (Invitrogen), the vector linearized and an in vitro transcription reaction conducted with a DIG labeling mix (Roche). Sections were post-fixed with PFA (4% for 10mins) before pretreatment with proteinase K (1 μg/ml for 10mins), and acetylated (0.1M triethanolamine, 0.25% acetic anhydride, 15mins). Following a prehybridization step (4hrs at RT) in hybridization buffer (10mM Tris pH7.5, 600mM NaCl, 1mM EDTA, 0.25% SDS, 10% Dextran Sulfate, 1x Denhartdt's, 200 μg/ml yeast tRNA) the denatured probe was applied, and hybridized overnight at 60°C in a custom-built hybridization chamber. Post hybridization washes and RNase treatment were performed as previously described ([@bib24]). Staining was visualized by incubating sections with an alkaline phosphatase conjugated digoxigenin antibody (1:2000, 4°C, overnight), followed by the application of BM-Purple AP.Real-Time Quantitative PCREmbryonic (E10.5, E12.5, E14.5, E16.5, E18.5), postnatal (P0, P6) and adult (8 weeks) tissues (C57/BL6) were dissected and snap frozen, before mRNA extraction employing either an RNeasy lipid tissue kit or an RNeasy fibrous tissue kit. RNA was extracted from three independent samples at the same developmental time point, brain region or organ, quantified and then pooled for reverse transcription (SuperScript III First-Strand Synthesis System, Invitrogen, 18080-051). For human studies fetal brain cDNA was obtained from Biochain (C1244051, C1244035). For quantitative real-time PCR we designed intron-spanning primers employing the Primer3 program, and undertook BLAST searches to confirm their specificity (see [Table S1](#mmc1){ref-type="supplementary-material"}). Following efficiency testing, we did quantitative real-time PCR with SYBR green on a Bio-Rad Cycler together with negative controls. To maximize the accuracy of our real-time PCR experiments we used three internal control genes for our mouse (Pgk1, Tfrc, and Hprt) and human studies (HPRT, PGK1, TBP), and calculated the geometric mean as previously described ([@bib25]).Generation and Cellular Validation of shRNA ConstructsShort hairpin RNAs for *Tubb5* knockdown were cloned into the pSuper vector system according to the manufacturer's instructions (*VEC-pBS-0002*). The efficiency of the short hairpin (see [Table S1](#mmc1){ref-type="supplementary-material"}) was assessed by quantitative real-time PCR 36 and 72 hr post transfection of the constructs with Lipofectamine 2000 (Invitrogen, 11668-027) into Neuro-2a cells. RNA extraction (Roche, High Pure RNA Isolation Kit) and cDNA synthesis (Roche, Expand Reverse Transcriptase) were performed in accordance with the manufacturers' protocol. Quantitative real-time PCR utilized the SYBR green dye on a Roche LightCycler. *Tubb5* expression levels were normalized relative to *Hprt* (see [Table S1](#mmc1){ref-type="supplementary-material"}).Cellular StudiesNeuro-2a cells were kept under standard cell culture conditions in DMEM supplemented with 10% FBS (Sigma, F7524), 1% L-Glu (Sigma, G7513) and 1% PenStrep (Sigma, P0781). DNA constructs were transfected with Oligofectamine (Invitrogen, 12252-011) according to the manufacturer's protocol. Immunostaining employing an anti-α-tubulin antibody (Sigma, T6199-200UL) and anti-FLAG antibody (Abcam, ab1162) was performed as previously described ([@bib9]).In Utero Electroporation ExperimentsSequence-verified expression constructs for wild-type and mutant versions of *Tubb5* were cloned by PCR amplification of the coding sequence followed by ligation into the EcoRI/XhoI site of pCIG2. In utero electroporation was performed as described previously ([@bib7]; [@bib17]). High-quality, low-endotoxin plasmid preparations (QIAGEN) of GFP expression vector (pCIG2) and shRNA vectors were injected at 1 μg/μl for each plasmid, together with Fast Green (0.05%, Sigma). Electroporation of telencephalic vesicles of DNA-injected embryos was achieved using platinum electrodes (Nepagene) connected to an electroporator (ECM830, BTX) to deliver five pulses of 30 V (50 ms duration) at 1 s intervals. Control electroporations for knockdown experiments were performed with a scrambled shRNA in the pSuper vector with an empty pCIG2 vector. Control electroporations for *Tubb5* overexpression studies were performed with an empty pCIG2 vector together with an empty pSuper vector. Pregnant dams were sacrificed by cervical dislocation, and the embryonic brains dissected and fixed in 4% PFA in PBS overnight. Following three washes in PBS, the brains were incubated in 20% sucrose/PBS overnight before embedding in optimal cutting temperature compound. Cryosectioning (16 μm) was performed on a freezing microtome (Leica). Fluorescence immunostaining was performed as previously described ([@bib7]), and images were captured on an epifluorescence microscope (Olympus) equipped with a CCD camera (SPOT). Subdivisions of the embryonic cortex (VZ, SVZ, IZ, and CP) were identified based on cell density as visualized with DAPI (4′6-diamidino-2-phenylindole) staining. Cell counting was performed blind to the condition on representative fields of sections of electroporated brains using ImageJ software. Immunostaining for activated (cleaved) caspase-3 utilized a rabbit polyclonal antibody (AB3623, Merck Millipore) at a 1:1,000 dilution.In Vitro Transcription/Translation ReactionsPlasmids engineered for the T7-driven expression of wild-type, M299V, V353I, and E401K TUBB5 were used to drive expression in rabbit reticulocyte lysate (Promega) containing ^35^S-methionine as described ([@bib20]). At various intervals, aliquots were withdrawn and analyzed on native polyacrylamide gels. In some cases, the reactions were supplemented (to a final concentration of 0.2 mg/ml) with native bovine brain tubulin after 90 min and the incubation continued for a further 30 or 90 min.
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![*Tubb5* Is Highly Expressed in the Developing Mouse and Human Brain\
(A) Relative expression levels of β-tubulin genes in the developing mouse brain determined by quantitative real-time PCR at E10.5, E12.5, E14.5, E16.5, and E18.5 and postnatal days zero (P0) and six (P6) (n = 3). Note the early onset and consistently high expression of *Tubb5*.\
(B) Relative expression levels of all the human β-tubulin genes in the developing brain at GW13 and GW22.\
(C--H) In situ hybridization results obtained with an antisense probe specific for *Tubb5* at E12.5 (C and D), E14.5 (E and F), and E16.5 (G and H). (D), (F), and (H) show higher magnifications of (C), (E), and (G), respectively. *Tubb5* is detected throughout the developing cortex with strong expression in the preplate at E12.5, and in the SVZ at E14.5.\
(I--X) Antibody staining for Dcx (I--L), Tuj (M-P), Tbr2 (Q--T), and Pax6 (U--X) performed on coronal sections of the Tg (Tubb5-EGFP) mouse line at E14.5. Grey scale images of (J), (N), (R), and (V) are shown in (K) and (L), (O) and (P), (S) and (T), and (W) and (X). All markers were found to colocalize with or in GFP-positive cells.\
Scale bars show 500 μm in (C), (E), and (G); 50 μm in (D), (F), and (H); 50 μm in (U); and 10 μm in (V). Error bars in (A) and (B) show SEM. See also [Figure S1](#figs1){ref-type="fig"}.](gr1){#fig1}

![*Tubb5* Depletion Perturbs Progenitor Mitosis and Alters the Positioning of Postmitotic Neurons\
(A) Schematic illustrating the three different in utero electroporation experiments. After electroporation at E14.5, embryos were harvested 36 hr later to assess the mitotic index, harvested 72 hr later to assess the migration index, or harvested at P17 to assess the positioning index.\
(B) Quantitation of the mitotic index, showing the relative proportion of GFP positive cells that are also pH3 positive in the VZ and SVZ, IZ, and across all zones (Total) for the following conditions: scrambled shRNA (scrshRNA); shRNA targeting *Tubb5* (shRNA); overexpression of *Tubb5* (pCIG2 *Tubb5*); and the rescue experiment (pCIG2-*Tubb5* + shRNA). Note that *Tubb5* depletion results in a significant increase in the mitotic index in comparison to the scrambled control, overexpression, and rescue experiments (n ≥ 5; VZ and SVZ: p \< 0.001; Total: p \< 0.05).\
(C and D) Representative images for the mitotic index experiment. Arrowheads highlight colocalization of GFP-expressing cells (green) with pH3 staining (red).\
(E and F) Representative images showing the migration assessment following *Tubb5* depletion. Note the conspicuous reduction in the proportion of GFP-positive cells reaching the CP.\
(G) Quantification of the percentage of GFP-positive cells in the VZ, IZ, CP, and marginal zone (MZ) for the migration index following treatment with a scrshRNA; an shRNA targeting *Tubb5* (shRNA); a *Tubb5* expression construct (pCIG2 *Tubb5*); and the rescue experiment (shRNA + pCIG2 *Tubb5*). *Tubb5* depletion results in a moderate but significant increase in the percentage of GFP-positive cells located in the VZ and IZ and a decrease in the percentage of GFP-positive cells in the CP (n ≥ 5, VZ: p \< 0.05; IZ: p \< 0.05; CP: p \< 0.01). This phenotype was partially rescued by coexpression of a *Tubb5* isotype lacking the shRNA targeting sequence (pCIG2 *Tubb5* + shRNA). Note that overexpression of *Tubb5* by itself has no effect on migration (pCIG2 *Tubb5*).\
(H) Quantification of the percentage of GFP-positive cells in the six layers of the P17 cortex following treatment with an scrshRNA and a shRNA targeting *Tubb5*. *Tubb5* depletion results in a significant increase in the percentage of neurons in layer VI (n = 4; p \< 0.05), with a concomitant decrease in layers II--IV (n = 4; p \< 0.01).\
(I and J) Representative images for the positioning index in (H). The red channel shows Cux1 staining in layers II--IV.\
Scale bars show 50 μm in (D), 100 μm in (F), and 200 μm in (J). Error bars in (B), (G), and (H) show mean ± SEM.^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. MZ, marginal zone; scrshRNA, scrambled shRNA. See also [Figure S2](#figs2){ref-type="fig"}.](gr2){#fig2}

![Mutations in *TUBB5* Cause Microcephaly and Affect the Generation of Tubulin Heterodimers in Different Ways\
(A--F) Coronal (A and D), sagittal (B and E), and horizontal (C and F) MRIs of two patients with *TUBB5*-associated microcephaly (M299V and V353I). (A--C) The patient with the M299V mutation has microcephaly (OFC of −2.5 SD), focal polymicrogyria (shown with arrowheads in A), severe brainstem hypoplasia (shown with an arrowhead in B), partial agenesis of the corpus callosum (shown with an arrow in B), and dysmorphic basal ganglia with streaks of white matter (highlighted with an arrowhead in C). (D--F) The patient with the V353I mutation has microcephaly (OFC of −4.0 SD), a hypoplastic corpus callosum (shown with an arrow in E), and a dysmorphic basal ganglia with streaks of white matter running through the lenticular nucleus (shown with an arrowhead in F).\
(G) Structural representation of a tubulin heterodimer highlighting the positions of the mutated residues. The M299 residue is centrally located and is associated with a deep hydrophobic pocket. V353 lies on the intradimer interface, in contrast to E401, which is located at the interdimer interface.\
(H--J) Higher-resolution images showing the mutated residues within the three-dimensional structure of the tubulin heterodimer. (H) The M299 side chain is surrounded by hydrophobic residues (M267, P305, Y310, F367, shown in green) that could be disrupted by replacement with valine. (J) E401 lies in proximity to a loop (98--104, shown in green) that is critical for the binding of GTP (shown in yellow).\
(K) Denaturing gel of in vitro ^35^S-methionine-labeled transcription/translation reaction products for wild-type and TUBB5 mutants showing similar translational efficiencies.\
(L) Kinetic analysis on nondenaturing gels of the products of in vitro transcription/translation reactions for wild-type and TUBB5 mutants. Arrows (top to bottom) denote the migration positions of the chaperonin (CCT)/β-tubulin binary complex (CCT/β), the TBCD/β-tubulin cocomplex, the prefoldin (PFD)/β-tubulin binary complex (PFD/β), the native tubulin heterodimer (α/β), and the TBCA/β-tubulin cocomplex (TBCA/β), each assigned on the basis of their characteristic electrophoretic mobilities. Note that the V353I mutant polypeptide behaved similarly to wild-type controls, whereas there was a diminished heterodimer yield in the case of M299V and little or no detectable heterodimer in the case of E401K. Note also the absence of TBCA/β-tubulin and TBCD/β-tubulin cocomplexes and a relatively long persistence of the PFD/β-tubulin cocomplex in the case of reactions performed with the E401K mutation. Min. chase indicates that reaction products generated after 90 min were further chased with added native bovine brain tubulin so as to drive the generation of tubulin heterodimers for the times shown.\
(M--X) Expression of FLAG-tagged wild-type and mutant (M299V, V353I, and E401K) TUBB5 in cultured Neuro-2a cells. Staining with the anti-FLAG antibody is shown in red and the microtubule cytoskeleton visualized using an anti-α-tubulin antibody (shown in green). Note that wild-type FLAG-tagged TUBB5, as well as the corresponding M299V and V353I mutants, incorporated into the microtubule lattice (M--O, P--R, and S--U, respectively). This contrasts with the E401K protein, which is distributed throughout the cytoplasm and failed to incorporate into the cytoskeletal network (V--X). Scale bar in (X) is 10 μm.\
See also [Figure S3](#figs3){ref-type="fig"}.](gr3){#fig3}

![Expression of Disease-Causing *Tubb5* Mutations In Vivo\
(A) Quantification of the mitotic index for cells electroporated with control vectors (ctrl), a *Tubb5* expression vector (pCIG2-*Tubb5*; note that this control is also presented in [Figure 2](#fig2){ref-type="fig"}B), and the mutants identified (pCIG2-*Tubb5*(M299V), pCIG2-*Tubb5*(V353I), pCIG2-*Tubb5*(E401K)). *Tubb5* overexpression resulted in a mitotic index that was comparable to controls. In contrast, there was a large increase in the percentage of GFP-positive cells that are also pH3 positive in the VZ and SVZ when expressing the E401K and V353I mutant constructs (n ≥ 5; E401K and V353I: VZ + SVZ: p \< 0.001; Total: p \< 0.001). This increase in the mitotic index was also apparent when overexpressing the M299V mutation, although the effect was not statistically significant (n ≥ 5; p \> 0.05).\
(B) Quantification of the migration index for all five conditions (note that the *Tubb5* overexpression control is also presented in [Figure 2](#fig2){ref-type="fig"}G). Overexpression of the mutants results in an accumulation of GFP-positive cells in the IZ with a concomitant decrease in the CP (n = 5; M299V: IZ: p \< 0.001; CP: p \< 0.01; V353I: VZ: p \< 0.01; IZ: p \< 0.001; CP: p \< 0.001; E401K: IZ: p \< 0.01; CP: p \< 0.05) that was not observed when overexpressing *Tubb5* alone (n = 5, p \> 0.05).\
(C--E) Representative images used for mitotic index assessment with arrowheads showing colocalization of GFP-expressing cells (green) with pH3 staining (red).\
(F--I) Representative images used for migration assessment. Note the decrease in the relative number of cells reaching the upper layers of the cortex when expressing the mutant constructs in comparison to controls (^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001).\
Scale bars show 50 μm in (E) and 100 μm in (I). (A) and (B) show mean ± SEM. See also [Figure S4](#figs4){ref-type="fig"}.](gr4){#fig4}

![Negative Controls for [Figure 1](#fig1){ref-type="fig"} and Analysis of the Tg(Tubb5-EGFP) Mouse Line\
(A--C) Negative controls (sense probe) for the in situ hybridization experiments shown in [Figure 1](#fig1){ref-type="fig"} for the indicated time points (E12.5, E14.5, E16.5).\
(D--F) Littermate control of the Tg(Tubb5-EGFP) embryo shown in [Figure 1](#fig1){ref-type="fig"}, negative for the GFP transgene. Images were captured employing the same settings as those shown in (G)-(Q); no background fluorescence can be detected.\
(G--Q) Representative coronal (G, I-K, M-O, Q) and sagittal (H, L, P) sections of Tg(Tubb5-EGFP) embryos at the indicated time points (E12.5, E14.5, E16.5). (I) and (M) show magnifications of the boxed regions shown in (G) and (K). High magnification confocal images of the developing cortex are shown in (J), (N), (Q). Note the robust expression of EGFP throughout the developing cortex, consistent with our in situ studies. Scale bars show 1000 μm for (A--C), (G), (H), (K), (L), (O) and (P), 500 μm in (F), 50 μm for (J), (N) and (Q). DAPI staining (shown in blue) is visible in (G), (H), (K), (L), (O) and (P).](figs1){#figs1}

![Supplemental Information to [Figure 2](#fig2){ref-type="fig"} and Assessment of Apoptosis\
(A) Relative expression level of *Tubb5* mRNA in Neuro2a cells following transfection with a pSuper vector driving expression of a shRNA targeted to the 3′ UTR of this gene. This results in a ∼62% knockdown (36 hr) and ∼77% knockdown (72 hr) of *Tubb5* mRNA levels. The error bars show the SEM (n = 3 independent experiments for each time point).\
(B and C) Representative images for the assessment of neuronal positioning following electroporation of pCIG2 *Tubb5* and pCIG2 *Tubb5* + shRNA.\
(D and E) Representative images for the mitotic index assessment when electroporating with pCIG2 *Tubb5* and pCIG2 *Tubb5* + shRNA.\
(F--N) Representative image of the apoptosis experiments showing the GFP channel (F-H), activated caspase-3 staining (I-K) and the merged image (L-N). Boxed regions in F, I and L are shown in the adjacent panels (G, J, M) and (H, K, N). Panels H, K and N highlight the mediodorsal region of the cortex as an internal positive control for caspase-3 staining. The magnified region in H, K and N show an apoptotic cell positive for caspase-3.\
(O) Quantification of GFP+ cells co-localizing with activated capase-3. All conditions show less than 1% of co-localization. An ANOVA followed by a multiple comparison test revealed no significant difference between the relevant experiments (scrshRNA, shRNA, pCIG2 *Tubb5* and pCIG2 *Tubb5* + shRNA; ctrl, pCIG2 *Tubb5*, pCIG2 *Tubb5*(M299V), pCIG2 *Tubb5*(V353I) and pCIG2 *Tubb5*(E401K)).\
Scale bars show 50 μm in (C), 100 μm in (E), and 200 μm in (L).](figs2){#figs2}

![Supplemental Information to [Figure 3](#fig3){ref-type="fig"}\
(A--C) Sequencing traces for patients and parents showing the mutations in *TUBB5* for M299V, V353I, and E401K together with the amino acid conversions. All mutations are de novo. (D) Protein sequence alignment of β-tubulins present in humans (upper panel). Note the high conservation between the isoforms for all three loci, with the exception of T299 in TUBB1, the most distinct of the human isoforms. The lower panel shows an alignment of TUBB5 homologs in a variety of species. Note that the three disease causing residues are conserved from yeast to man. (E and F) Horizontal (E) and sagittal (F) MRI images taken at 4 months of age for the patient harboring the E401K mutation. This individual presented with microcephaly (−4 SD OFC), partial posterior agenesis of the corpus callosum, and dysmorphic basal ganglia.](figs3){#figs3}

![Positioning Index following Expression of Mutant Tubb5 In Vivo, Related to [Figure 4](#fig4){ref-type="fig"}\
(A--E) Representative images of P17 mouse brains following in utero electroporation at E14.5 with plasmids expressing: (A) scrambled shRNA; (B) *Tubb5* wt; (C) *Tubb5* M299V, (D) *Tubb5* V353I, and (E) *Tubb5* E401K. The cortical regions analyzed are indicated in A. The red channel shows Cux1 staining in layers II-IV. Note the increased number of ectopic cells in deep cortical layers when overexpressing the *Tubb5* mutants (M299V, V353I, E401K).\
(F) Quantification of the percentage of GFP positive cells in layers I-VI of the P17 cortex for all five conditions (note that the control is also presented in [Figure 2](#fig2){ref-type="fig"}H; see also [Table S2](#mmc1){ref-type="supplementary-material"}). Overexpression of the *Tubb5* mutants results in fewer cells in superficial layers of the cortex (M299V; II-IV: p \< 0.05, E401K; II-IV: p \< 0.001), and an accumulation of GFP positive cells in the deeper layers (E401K; n = 3; VI: p \< 0.01), but this was not significant in the case of the V353I mutation (n = 3; p \> 0.05). Magnification of the boxed regions in (C), (D), and (E), showing ectopic clusters of GFP positive cells. Note that a number of these cells are also positive for the post-mitotic marker Cux 1. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. Data are mean ± SEM.\
Scale bars show 200 μm in (E) and 100 μm in (I).](figs4){#figs4}

###### 

Summary of Clinical, Neurological, Biochemical, Cellular and In Vivo Data Associated with *TUBB5* Mutations

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------
                                      *M299V*                                            *V353I*                                *E401K*
  ----------------------------------- -------------------------------------------------- -------------------------------------- -----------------------------------
  Ethnicity/Origin                    Caucasian                                          Sri Lanka                              Vietnam/Caucasian

  Sex                                 Male                                               Male                                   Female

  Age at last evaluation              2 years 6 months                                   4 years 10 months                      2 years 8 months

  OFC at birth                        32 cm (−3 SD)                                      31 cm (−3 SD)                          28.5 cm (−4 SD)

  OFC at last evaluation              −2.5 SD                                            46.5 cm (−4 SD)                        42 cm (−4 SD)

  Cortical dysgenesis                 Focal polymicrogyria, localized band heterotopia   None apparent                          None apparent at 4 months

  Basal ganglia                       Dysmorphic\                                        Dysmorphic\                            Dysmorphic
                                      White matter streaks                               White matter streaks                   

  Cerebellum                          Hypoplastic and dysplastic cerebellar vermis       Possible white matter abnormalities.   Large 4th ventricle

  Corpus callosum                     Partial agenesis                                   Thin and short but complete            Partial posterior agenesis

  Cognitive abilities                 Severe MR                                          MR (global DQ:48)                      Mild developmental delay

  Verbal abilities                    Severe language delay                              Limited language\                      Delayed
                                                                                         Speech delay.                          

  Motor abilities                     Severe motor delay, ataxia                         Motor delay. Walked at 21 months.      Motor delay. Walked at 25 months

  Other                               Retina dysplasia and micro-ophthalmia              None apparent.                         Prenatal diagnosis of cardiopathy

  Family history                      None                                               Mother's OFC is −4 SD\                 None
                                                                                         Brother's OFC is −2 SD\                
                                                                                         Sister's OFC is −1 SD                  

  Heterodimer folding                 Slightly impaired                                  Not affected                           Severely impaired

  Microtubule lattice incorporation   Not affected                                       Not affected                           No incorporation

  Mitotic index                       n.s.                                               Significantly increased                Significantly increased

  Migration index                     Significantly decreased                            Significantly decreased                Significantly decreased

  Positioning index                   Affected                                           n.s.                                   Affected

  Ectopic clusters at P17             Yes                                                Yes                                    Yes
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------

OFC, orbitofrontal cortex; MR, mental retardation; DQ, development quotient; n.s., nonsignificant.

[^1]: These authors contributed equally to this work
